PCI Biotech Holding ASA

05/04/2022 | Press release | Distributed by Public on 05/04/2022 03:12

Notice of Annual General Meeting 2022

Notice of Annual General Meeting 2022

Subscribe

04 May 2022 11:00 CEST

Company Name

PCI BIOTECH HOLDING

ISN

NO0010405640

Market

Oslo Børs

Symbol

PCIB

Oslo, Norway 4 May 2022 - The annual general meeting of PCI Biotech Holding ASA
will be held at the company's office at Oslo Cancer Cluster Innovation Park, on
25 May 2022 at 10:00am (CEST).

The notice including attendance and proxy forms will be mailed to all
shareholders with known address. The complete notice, including the board of
directors' proposed resolutions for the items listed on the agenda, the
recommendation of the nomination committee, the annual accounts and annual
report for the financial year 2021, including the corporate governance report
for 2021 and the remuneration report of executive management for 2021 are
attached to this notification and will also be made available at PCI Biotech's
corporate website www.pcibiotech.com (http://www.pcibiotech.com).

The notice including attendance and proxy forms, the board of directors'
proposed resolutions for the items listed on the agenda and the proposal from
the nomination committee are attached hereto in both English and Norwegian.

For further information, please contact:
Ronny Skuggedal, CFO, E-mail: [email protected]
Office: +47 67 11 54 00 Mobile: +47 94 00 57 57

This information is subject to the disclosure requirements pursuant to section
5 -12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site

561049_PCI Biotech Holding ASA Notice of AGM 2022.pdf
561049_PCI Biotech Holding ASA Proposed resolutions for the AGM 2022.pdf
561049_2021 Annual report PCI Biotech Holding ASA.pdf
561049_PCI Biotech Holding ASA Remuneration Report 2021.pdf
561049_PCI Biotech Holding ASA Valgkom Innst_NomCom Proposal AGM 2022.pdf
561049_PCI Biotech Holding ASA Innkalling GF 2022.pdf
561049_PCI Biotech Holding ASA Forslag til beslutninger GF 2022.pdf

Source

PCI Biotech Holding ASA

Provider

Oslo Børs Newspoint